Financials Kanabo Group Plc

Equities

KNB

GB00BYQCS703

Pharmaceuticals

Market Closed - London S.E. 11:35:00 2024-04-29 am EDT 5-day change 1st Jan Change
1.7 GBX 0.00% Intraday chart for Kanabo Group Plc -2.86% -39.29%

Valuation

Fiscal Period: December 2021 2022
Capitalization 1 51.8 8.035
Enterprise Value (EV) 1 47.3 5.023
P/E ratio -9.98 x -1.15 x
Yield - -
Capitalization / Revenue 710 x 13.3 x
EV / Revenue 648 x 8.33 x
EV / EBITDA -13.9 x -1.14 x
EV / FCF -192,176,459 x -8,144,961 x
FCF Yield -0% -0%
Price to Book 9.99 x 0.65 x
Nbr of stocks (in thousands) 369,966 422,916
Reference price 2 0.1400 0.0190
Announcement Date 6/1/22 5/2/23
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022
Net sales 1 0.06 0.073 0.603
EBITDA 1 -0.558 -3.395 -4.42
EBIT 1 -0.563 -3.402 -5.333
Operating Margin -938.33% -4,660.27% -884.41%
Earnings before Tax (EBT) 1 -0.591 -4.551 -6.87
Net income 1 -0.591 -4.551 -6.867
Net margin -985% -6,234.25% -1,138.81%
EPS 2 -0.002558 -0.0140 -0.0165
Free Cash Flow - -0.2461 -0.6168
FCF margin - -337.15% -102.28%
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 6/1/22 6/1/22 5/2/23
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022
Net Debt 1 0.04 - -
Net Cash position 1 - 4.5 3.01
Leverage (Debt/EBITDA) -0.0699 x - -
Free Cash Flow - -0.25 -0.62
ROE (net income / shareholders' equity) - -177% -77.9%
ROA (Net income/ Total Assets) - -70% -33.2%
Assets 1 - 6.497 20.65
Book Value Per Share 2 -0 0.0100 0.0300
Cash Flow per Share 2 0 0.0100 0.0100
Capex - 0.04 0.07
Capex / Sales - 47.95% 11.28%
Announcement Date 6/1/22 6/1/22 5/2/23
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. KNB Stock
  4. Financials Kanabo Group Plc